<DOC>
	<DOC>NCT01050062</DOC>
	<brief_summary>The survey is conducted to collect safety and effectiveness information in Hypertensive patients treated with Micombi Tablets on the long term use in daily clinical settings in Japan.</brief_summary>
	<brief_title>Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Inclusion criteria: Hypertensive patients who have never taken Micombi Tablets. Exclusion criteria:</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>